Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ICUI's Cash to Debt is ranked higher than
91% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. ICUI: No Debt )
ICUI' s 10-Year Cash to Debt Range
Min: 1.75   Max: No Debt
Current: No Debt

Equity to Asset 0.93
ICUI's Equity to Asset is ranked higher than
97% of the 275 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. ICUI: 0.93 )
ICUI' s 10-Year Equity to Asset Range
Min: 0.85   Max: 0.96
Current: 0.93

0.85
0.96
Interest Coverage No Debt
ICUI's Interest Coverage is ranked higher than
81% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.42 vs. ICUI: No Debt )
ICUI' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 5
Z-Score: 24.36
M-Score: -3.21
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 13.19
ICUI's Operating margin (%) is ranked higher than
83% of the 286 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. ICUI: 13.19 )
ICUI' s 10-Year Operating margin (%) Range
Min: 7.83   Max: 34.17
Current: 13.19

7.83
34.17
Net-margin (%) 10.51
ICUI's Net-margin (%) is ranked higher than
84% of the 286 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.97 vs. ICUI: 10.51 )
ICUI' s 10-Year Net-margin (%) Range
Min: 6.62   Max: 22.42
Current: 10.51

6.62
22.42
ROE (%) 6.88
ICUI's ROE (%) is ranked higher than
72% of the 276 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.15 vs. ICUI: 6.88 )
ICUI' s 10-Year ROE (%) Range
Min: 3.2   Max: 16.19
Current: 6.88

3.2
16.19
ROA (%) 6.40
ICUI's ROA (%) is ranked higher than
81% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.87 vs. ICUI: 6.40 )
ICUI' s 10-Year ROA (%) Range
Min: 3.04   Max: 14.64
Current: 6.4

3.04
14.64
ROC (Joel Greenblatt) (%) 25.32
ICUI's ROC (Joel Greenblatt) (%) is ranked higher than
81% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.54 vs. ICUI: 25.32 )
ICUI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 8.82   Max: 74.5
Current: 25.32

8.82
74.5
Revenue Growth (%) 0.20
ICUI's Revenue Growth (%) is ranked higher than
65% of the 261 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. ICUI: 0.20 )
ICUI' s 10-Year Revenue Growth (%) Range
Min: 0.2   Max: 34.6
Current: 0.2

0.2
34.6
EBITDA Growth (%) -0.10
ICUI's EBITDA Growth (%) is ranked higher than
69% of the 219 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. ICUI: -0.10 )
ICUI' s 10-Year EBITDA Growth (%) Range
Min: -19.8   Max: 35.1
Current: -0.1

-19.8
35.1
EPS Growth (%) 7.10
ICUI's EPS Growth (%) is ranked higher than
74% of the 218 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. ICUI: 7.10 )
ICUI' s 10-Year EPS Growth (%) Range
Min: -32.2   Max: 66
Current: 7.1

-32.2
66
» ICUI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

ICUI Guru Trades in Q4 2013

Joel Greenblatt 133,533 sh (New)
Paul Tudor Jones 15,959 sh (+77.32%)
Jim Simons 598,500 sh (+51.67%)
Mario Gabelli 69,733 sh (+45.18%)
Steven Cohen Sold Out
Chuck Royce 700 sh (-95.71%)
» More
Q1 2014

ICUI Guru Trades in Q1 2014

Steven Cohen 3,930 sh (New)
Joel Greenblatt 242,621 sh (+81.69%)
Mario Gabelli 115,000 sh (+64.91%)
Jim Simons 732,201 sh (+22.34%)
Chuck Royce 700 sh (unchged)
Paul Tudor Jones 4,115 sh (-74.22%)
» More
Q2 2014

ICUI Guru Trades in Q2 2014

Paul Tudor Jones 84,249 sh (+1947.36%)
Mario Gabelli 125,600 sh (+9.22%)
Chuck Royce 700 sh (unchged)
Joel Greenblatt 224,111 sh (-7.63%)
Jim Simons 645,500 sh (-11.84%)
» More
Q3 2014

ICUI Guru Trades in Q3 2014

Paul Tudor Jones 85,463 sh (+1.44%)
Chuck Royce 700 sh (unchged)
Mario Gabelli 122,200 sh (-2.71%)
Jim Simons 557,900 sh (-13.57%)
Joel Greenblatt 118,526 sh (-47.11%)
» More
» Details

Insider Trades

Latest Guru Trades with ICUI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-09-30 Reduce -47.11%0.08%$57.07 - $65.23 $ 83.6336%118526
Joel Greenblatt 2014-03-31 Add 81.69%0.1%$56.75 - $66.2 $ 83.6336%242621
Mario Gabelli 2014-03-31 Add 64.91%0.01%$56.75 - $66.2 $ 83.6336%115000
Joel Greenblatt 2013-12-31 New Buy0.2%$60.86 - $68.32 $ 83.6330%133533
Mario Gabelli 2013-12-31 Add 45.18%0.01%$60.86 - $68.32 $ 83.6330%69733
Mariko Gordon 2013-09-30 Sold Out 1.9%$67.84 - $75.9 $ 83.6317%0
John Hussman 2013-09-30 Sold Out 0.05%$67.84 - $75.9 $ 83.6317%0
Mario Gabelli 2013-09-30 Add 75.73%0.01%$67.84 - $75.9 $ 83.6317%48033
Mariko Gordon 2013-06-30 New Buy1.9%$58.34 - $75.7 $ 83.6326%550761
Joel Greenblatt 2013-06-30 Sold Out 0.13%$58.34 - $75.7 $ 83.6326%0
John Hussman 2013-06-30 Reduce -48.15%0.03%$58.34 - $75.7 $ 83.6326%14000
Mario Gabelli 2013-06-30 Add 22.39%$58.34 - $75.7 $ 83.6326%27333
John Hussman 2013-03-31 New Buy0.06%$56.07 - $63.91 $ 83.6339%27000
Joel Greenblatt 2012-03-31 Add 68.36%0.08%$44.41 - $49.53 $ 83.6392%44727
Joel Greenblatt 2011-12-31 Add 74.83%0.06%$35.99 - $45.53 $ 83.63102%26566
Joel Greenblatt 2011-09-30 Add 59.36%0.03%$36.41 - $45.79 $ 83.63105%15195
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about ICU Medical Inc

Weekly CEO Buys Highlight: GE, ICUI, OPK, CLMS, AHH
According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below: Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 40.70
ICUI's P/E(ttm) is ranked higher than
76% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 42.50 vs. ICUI: 40.70 )
ICUI' s 10-Year P/E(ttm) Range
Min: 13.77   Max: 106.63
Current: 40.7

13.77
106.63
P/B 2.60
ICUI's P/B is ranked higher than
78% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.51 vs. ICUI: 2.60 )
ICUI' s 10-Year P/B Range
Min: 1.4   Max: 3.45
Current: 2.6

1.4
3.45
P/S 4.30
ICUI's P/S is ranked higher than
64% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.92 vs. ICUI: 4.30 )
ICUI' s 10-Year P/S Range
Min: 1.73   Max: 6.58
Current: 4.3

1.73
6.58
PFCF 24.80
ICUI's PFCF is ranked higher than
89% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 719.57 vs. ICUI: 24.80 )
ICUI' s 10-Year PFCF Range
Min: 11.24   Max: 76.33
Current: 24.8

11.24
76.33
EV-to-EBIT 24.03
ICUI's EV-to-EBIT is ranked higher than
80% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.27 vs. ICUI: 24.03 )
ICUI' s 10-Year EV-to-EBIT Range
Min: 7   Max: 71.3
Current: 24.03

7
71.3
PEG 5.75
ICUI's PEG is ranked higher than
85% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. ICUI: 5.75 )
ICUI' s 10-Year PEG Range
Min: 0.6   Max: 158.4
Current: 5.75

0.6
158.4
Shiller P/E 33.40
ICUI's Shiller P/E is ranked higher than
86% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 398.57 vs. ICUI: 33.40 )
ICUI' s 10-Year Shiller P/E Range
Min: 16.32   Max: 37.93
Current: 33.4

16.32
37.93
Current Ratio 14.51
ICUI's Current Ratio is ranked higher than
99% of the 275 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.72 vs. ICUI: 14.51 )
ICUI' s 10-Year Current Ratio Range
Min: 5.86   Max: 23.06
Current: 14.51

5.86
23.06
Quick Ratio 13.21
ICUI's Quick Ratio is ranked higher than
98% of the 275 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. ICUI: 13.21 )
ICUI' s 10-Year Quick Ratio Range
Min: 4.57   Max: 22
Current: 13.21

4.57
22

Valuation & Return

vs
industry
vs
history
Price/Net Cash 4.40
ICUI's Price/Net Cash is ranked higher than
96% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. ICUI: 4.40 )
ICUI' s 10-Year Price/Net Cash Range
Min: 2.24   Max: 575
Current: 4.4

2.24
575
Price/Net Current Asset Value 3.80
ICUI's Price/Net Current Asset Value is ranked higher than
95% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. ICUI: 3.80 )
ICUI' s 10-Year Price/Net Current Asset Value Range
Min: 2.05   Max: 62.78
Current: 3.8

2.05
62.78
Price/Tangible Book 2.70
ICUI's Price/Tangible Book is ranked higher than
83% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.41 vs. ICUI: 2.70 )
ICUI' s 10-Year Price/Tangible Book Range
Min: 1.37   Max: 4.51
Current: 2.7

1.37
4.51
Price/DCF (Projected) 1.70
ICUI's Price/DCF (Projected) is ranked higher than
85% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.87 vs. ICUI: 1.70 )
ICUI' s 10-Year Price/DCF (Projected) Range
Min: 0.79   Max: 2.63
Current: 1.7

0.79
2.63
Price/Median PS Value 1.50
ICUI's Price/Median PS Value is ranked higher than
63% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.20 vs. ICUI: 1.50 )
ICUI' s 10-Year Price/Median PS Value Range
Min: 0.6   Max: 2.45
Current: 1.5

0.6
2.45
Price/Graham Number 2.20
ICUI's Price/Graham Number is ranked higher than
88% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.72 vs. ICUI: 2.20 )
ICUI' s 10-Year Price/Graham Number Range
Min: 0.92   Max: 3.55
Current: 2.2

0.92
3.55
Earnings Yield (Greenblatt) 4.20
ICUI's Earnings Yield (Greenblatt) is ranked higher than
79% of the 284 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.00 vs. ICUI: 4.20 )
ICUI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.4   Max: 14.4
Current: 4.2

1.4
14.4
Forward Rate of Return (Yacktman) 5.90
ICUI's Forward Rate of Return (Yacktman) is ranked higher than
78% of the 247 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.17 vs. ICUI: 5.90 )
ICUI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -2.1   Max: 27.2
Current: 5.9

-2.1
27.2

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:IC7.Germany
ICU Medical, Inc. is a Delaware Corporation founded in 1984 and its initial public offering was in 1992. The Company is engaged in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications. Its products improve patient outcomes by helping to prevent bloodstream infections and protect healthcare workers and patients from exposure to infectious diseases or hazardous drugs and monitoring continuous cardiac output of critical care patients. The Company's complete product line includes custom infusion systems, closed delivery systems for hazardous drugs, needle free infusion connectors, catheters and cardiac monitoring systems. Its products are categorized into three main product lines: Infusion Therapy, Critical Care and Oncology. I.V. therapy lines, used in hospitals and ambulatory clinics, consist of a tube running from a bottle or plastic bag containing an I.V. solution to a catheter inserted in a patient's vein. The tube typically has several injection ports or Y-sites (conventionally, entry tubes covered by rubber caps) to which a secondary I.V. line can be connected to permit constant intravenous administration of medications, fluids and nutrients, and to allow instantaneous intravenous administration of emergency medication. Critical care products are used to monitor vital signs as well as specific physiological functions of key organ systems and Oncology: Oncology products are used to prepare and deliver hazardous medications such as those used in chemotherapy which, if released, can have harmful effects to the healthcare worker and environment. Manufacturing of its products involves injection molding of plastic and silicone parts, manual and automated assembly of the molded plastic parts, needles and other components, quality control inspection, packaging and sterilization. The Company currently sells all of its products to I.V. product manufacturers, independent distributors and direct sales to the end user. It competes with other manufacturers of closed system transfer devices for the safe handling of oncology drugs, notably Becton Dickinson, CareFusion and B Braun. The Company's products are subject to clearance by the United States Food and Drug Administration ("FDA") under a number of statutes including the Food Drug and Cosmetics Act ("FDC Act").
» More Articles for ICUI

Headlines

Articles On GuruFocus.com
EW: Potential for Capital Appreciation Oct 03 2014 
Weekly CEO Buys Highlight: GE, ICUI, OPK, CLMS, AHH Mar 10 2014 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 2,388 Shares Nov 29 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 18,831 Shares Nov 24 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,406 Shares Nov 15 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 3,691 Shares Nov 09 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,500 Shares Nov 08 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 5,684 Shares Nov 05 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,000 Shares Nov 03 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 9,496 Shares Nov 02 2010 


More From Other Websites
Nasdaq stocks posting largest percentage increases Nov 26 2014
Is Abaxis (ABAX) Worth Adding to Your Investment Portfolio? Nov 26 2014
PerkinElmer Inks $266M Deal to Buy Perten Instruments Nov 25 2014
Abaxis Plans Direct Market Approach, Buys Distributor in UK Nov 24 2014
Covidien's Bedside Patient Monitoring System Gets CE Mark Nov 24 2014
ICU Medical, Inc. to Present at the Piper Jaffray 26th Annual Healthcare Conference Nov 21 2014
ICU Medical, Inc. to Present at the Piper Jaffray 26th Annual Healthcare Conference Nov 21 2014
Cardica (CRDC) in Focus: Stock Tumbles 9.1% Nov 21 2014
ICU MEDICAL INC/DE Financials Nov 19 2014
Boston Scientific's Symphion System Marks 1st US Surgery Nov 18 2014
Can ICU Medical (ICUI) Run Higher on Strong Earnings Estimate Revisions? Nov 18 2014
Hanger, Inc. (HGR) Falls: Stock Goes Down 7.6% Nov 18 2014
ICU Medical (ICUI) Showing Signs Of Being Strong And Under The Radar Nov 14 2014
Qiagen Partners with Novartis for Companion Diagnostics Nov 13 2014
Exactech (EXAC) Down to Strong Sell On Dismal Q3 Results Nov 13 2014
ICU Medical (ICUI) Jumps: Stock Adds 12.6% in Session Nov 12 2014
Mid-Afternoon Market Update: Vivint Solar Dips After Wider-Than-Expected Q3 Loss; Rackspace Shares... Nov 11 2014
Street Talk: TWX, DRI, ZNGA, GRUB & ICUI Nov 11 2014
Omnicell Reports Mixed Q3, Positive on Surgichem Buyout Nov 11 2014
On the Move: Vodafone Up 5.2%; Regeneron Climbs 3.3%; ICU Medical Gains 14%; Isis Up 9% Nov 11 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK